Combined Ensemble Docking and Machine Learning in Identification of Therapeutic Agents with Potential Inhibitory Effect on Human CES1
The human carboxylesterase 1 (CES1), responsible for the biotransformation of many diverse therapeutic agents, may contribute to the occurrence of adverse drug reactions and therapeutic failure through drug interactions. The present study is designed to address the issue of potential drug interactio...
Main Authors: | Eliane Briand, Ragnar Thomsen, Kristian Linnet, Henrik Berg Rasmussen, Søren Brunak, Olivier Taboureau |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/15/2747 |
Similar Items
-
Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs
by: Masakiyo Hosokawa
Published: (2008-02-01) -
Rapid bioluminescence assay for monitoring rat CES1 activity and its alteration by traditional Chinese medicines
by: Jun Zhang, et al.
Published: (2020-06-01) -
An epididymis-specific carboxyl esterase CES5A is required for sperm capacitation and male fertility in the rat
by: Yan-Fei Ru, et al.
Published: (2015-04-01) -
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
by: Shannon Dow, et al.
Published: (2013-05-01) -
Targeting the C-Terminal Domain Small Phosphatase 1
by: Harikrishna Reddy Rallabandi, et al.
Published: (2020-05-01)